Skin Protectant For Babies And Kids Ointment
NDC Package 13709-352-01

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

Skin Protectant For Babies And Kids (skin protectant ointment) ointment is skin protectant use: apply as needed Diaper rash use:Change wet and soiled diapers promptlyCleanse the diaper area, and allow to dryApply ointment liberally with each diaper change, especially at bedtime or anytime when exposure to wet diapers may be prolonged. This formulation utilizes a ointment delivery system. Marketed by Neilmed Pharmaceuticals Inc., this product is identified by NDC 13709-352 and is authorized under FDA application M016.

Identification & Billing

NDC Package Code
13709-352-01
Package Description
1 TUBE in 1 CARTON / 113 g in 1 TUBE
Product Code
13709-352
11-Digit Billing Format
13709035201
RxNorm Crosswalk
  • RxCUI: 664981 - lanolin 15.5 % / petrolatum 53.4 % Topical Ointment
  • RxCUI: 664981 - lanolin 0.155 MG/MG / petrolatum 0.534 MG/MG Topical Ointment
  • RxCUI: 664981 - lanolin 15.5 GM per 100 GM / petrolatum 53.4 GM per 100 GM Topical Ointment

Clinical Specifications

Proprietary Name
Skin Protectant For Babies And Kids
Non-Proprietary Name
Skin Protectant Ointment
Substance Name
Lanolin; Petrolatum
Dosage Form
Ointment - A semisolid3 dosage form, usually containing <20% water and volatiles5 and >50% hydrocarbons, waxes, or polyols as the vehicle. This dosage form is generally for external application to the skin or mucous membranes.
Administration Route
Topical - Administration to a particular spot on the outer surface of the body. The E2B term TRANSMAMMARY is a subset of the term TOPICAL.
Active Ingredient(s)
Usage Information
Skin protectant use: apply as needed Diaper rash use:Change wet and soiled diapers promptlyCleanse the diaper area, and allow to dryApply ointment liberally with each diaper change, especially at bedtime or anytime when exposure to wet diapers may be prolonged

Regulatory & Marketing

Labeler Name
Neilmed Pharmaceuticals Inc.
Product Type
Human Otc Drug
FDA Application #
M016
Marketing Category
OTC MONOGRAPH DRUG -
Start Marketing Date
01-02-2026
Listing Expiration
12-31-2027
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 13709-352-01 identifies a specific commercial package of 1 tube in 1 carton / 113 g in 1 tube of Skin Protectant For Babies And Kids, a human over the counter drug labeled by Neilmed Pharmaceuticals Inc.. This ointment is formulated for topical use and contains lanolin; petrolatum as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Neilmed Pharmaceuticals Inc. on January 02, 2026. The current certification is valid through December 31, 2027.

How is this Neilmed Pharmaceuticals Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 13709035201. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
13709-352-01
11-Digit CMS (5-4-2)
13709-0352-01

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.